Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention

Part of paid clinical trials in Boston, Massachusetts.

Sponsor
Dana-Farber Cancer Institute
Study ID
NCT07662239
Status
Recruiting
Apply to this trial

Conditions

  • Bone Sarcoma
  • Sarcoma
  • Soft Tissue Sarcoma (STS)

Eligibility Criteria

Sex
ALL
Age
15 Years - 39 Years
Healthy Volunteers
Not accepted

Interventions

  • Exercise Triage and Personalized Exercise Program — BEHAVIORAL
    * Part 1: Completion of the EXCEEDS triage tool to assess physical function and determine appropriate referral to rehabilitation or exercise services. * Part 2: Eligible participants receive a 12-week personalized exercise program, which may be supervised or unsupervised, and includes a Garmin activity monitor, resistance bands, and a stepper machine.

Study Details

This study will evaluate strategies to improve physical function and promote exercise and physical activity in adolescents and young adults (AYAs) with sarcoma. The study will assess the feasibility of a standardized triage system for referring AYAs with sarcoma to appropriate exercise and rehabilitation services, and will also examine changes in physical function and health-related quality of life before and after a 12-week personalized exercise program.

Key Dates

First listed
Jun 23, 2026
Start date
Aug 1, 2026
Status verified
Jun 2026
Primary completion
Aug 1, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
40 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE

Arms

  • Experimental: Exercise Triage and Personalized Exercise Program
    All participants receive this intervention.

Primary Outcome Measure

Triage Tool Completion Rate [ Time Frame: 2 weeks ]

Central Contacts

Locations (3)

FacilityCityStateZIPSite coordinators
Boston Children's HospitalBostonMassachusetts02115
Chao Cao, MD
[email protected]
617-632-4237
Chao Cao, MD (PRINCIPAL_INVESTIGATOR)
Brigham and Women's HospitalBostonMassachusetts02115
Chao Cao, MD
[email protected]
617-632-4237
Chao Cao, MD (PRINCIPAL_INVESTIGATOR)
Dana-Farber Cancer InstituteBostonMassachusetts02115
Chao Cao, MD
[email protected]
617-632-4237
Chao Cao, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Boston, MA

By research site
Boston Children's Hospital· Boston, MABrigham and Women's Hospital· Boston, MADana-Farber Cancer Institute· Boston, MA

Related Studies